Atomistry » Fluorine » PDB 4f9w-4fvx » 4fod
Atomistry »
  Fluorine »
    PDB 4f9w-4fvx »
      4fod »

Fluorine in PDB 4fod: Crystal Structure of Human Anaplastic Lymphoma Kinase in Complex with Acyliminobenzimidazole Inhibitor 36

Enzymatic activity of Crystal Structure of Human Anaplastic Lymphoma Kinase in Complex with Acyliminobenzimidazole Inhibitor 36

All present enzymatic activity of Crystal Structure of Human Anaplastic Lymphoma Kinase in Complex with Acyliminobenzimidazole Inhibitor 36:
2.7.10.1;

Protein crystallography data

The structure of Crystal Structure of Human Anaplastic Lymphoma Kinase in Complex with Acyliminobenzimidazole Inhibitor 36, PDB code: 4fod was solved by D.A.Whittington, L.F.Epstein, H.Chen, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 36.20 / 2.00
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 51.717, 57.700, 105.939, 90.00, 90.00, 90.00
R / Rfree (%) 17.7 / 22.1

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Crystal Structure of Human Anaplastic Lymphoma Kinase in Complex with Acyliminobenzimidazole Inhibitor 36 (pdb code 4fod). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Crystal Structure of Human Anaplastic Lymphoma Kinase in Complex with Acyliminobenzimidazole Inhibitor 36, PDB code: 4fod:
Jump to Fluorine binding site number: 1; 2;

Fluorine binding site 1 out of 2 in 4fod

Go back to Fluorine Binding Sites List in 4fod
Fluorine binding site 1 out of 2 in the Crystal Structure of Human Anaplastic Lymphoma Kinase in Complex with Acyliminobenzimidazole Inhibitor 36


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Crystal Structure of Human Anaplastic Lymphoma Kinase in Complex with Acyliminobenzimidazole Inhibitor 36 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1501

b:16.4
occ:0.50
F1 A:0UV1501 0.0 16.4 0.5
F1 A:0UV1501 0.1 18.1 0.5
C12 A:0UV1501 1.3 15.1 0.5
C12 A:0UV1501 1.4 16.7 0.5
C13 A:0UV1501 2.4 14.6 0.5
C11 A:0UV1501 2.4 14.8 0.5
C13 A:0UV1501 2.4 16.2 0.5
C11 A:0UV1501 2.5 16.4 0.5
O A:GLY1269 3.3 19.5 1.0
CD1 A:LEU1196 3.3 21.7 1.0
CE A:LYS1150 3.5 22.9 1.0
C14 A:0UV1501 3.6 14.4 0.5
C10 A:0UV1501 3.6 14.5 0.5
C14 A:0UV1501 3.7 16.1 0.5
C10 A:0UV1501 3.7 16.2 0.5
NZ A:LYS1150 3.8 24.9 1.0
CG2 A:VAL1180 3.8 13.2 1.0
O A:HOH1623 3.9 21.4 1.0
CG A:LEU1196 4.1 19.9 1.0
C9 A:0UV1501 4.1 14.8 0.5
CD2 A:LEU1196 4.1 21.2 1.0
C9 A:0UV1501 4.2 16.6 0.5
CB A:LEU1196 4.2 18.1 1.0
C A:GLY1269 4.2 16.3 1.0
CD1 A:LEU1256 4.6 13.9 1.0
CA A:GLY1269 4.6 14.1 1.0
CB A:VAL1180 4.7 13.8 1.0
CD A:LYS1150 4.8 20.8 1.0
CG1 A:VAL1180 4.9 14.3 1.0

Fluorine binding site 2 out of 2 in 4fod

Go back to Fluorine Binding Sites List in 4fod
Fluorine binding site 2 out of 2 in the Crystal Structure of Human Anaplastic Lymphoma Kinase in Complex with Acyliminobenzimidazole Inhibitor 36


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Crystal Structure of Human Anaplastic Lymphoma Kinase in Complex with Acyliminobenzimidazole Inhibitor 36 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1501

b:18.1
occ:0.50
F1 A:0UV1501 0.0 18.1 0.5
F1 A:0UV1501 0.1 16.4 0.5
C12 A:0UV1501 1.3 15.1 0.5
C12 A:0UV1501 1.3 16.7 0.5
C11 A:0UV1501 2.3 14.8 0.5
C13 A:0UV1501 2.3 14.6 0.5
C13 A:0UV1501 2.4 16.2 0.5
C11 A:0UV1501 2.4 16.4 0.5
O A:GLY1269 3.2 19.5 1.0
CD1 A:LEU1196 3.4 21.7 1.0
CE A:LYS1150 3.5 22.9 1.0
C10 A:0UV1501 3.5 14.5 0.5
C14 A:0UV1501 3.6 14.4 0.5
C14 A:0UV1501 3.6 16.1 0.5
C10 A:0UV1501 3.6 16.2 0.5
NZ A:LYS1150 3.8 24.9 1.0
O A:HOH1623 3.9 21.4 1.0
CG2 A:VAL1180 3.9 13.2 1.0
C9 A:0UV1501 4.0 14.8 0.5
C9 A:0UV1501 4.1 16.6 0.5
CG A:LEU1196 4.1 19.9 1.0
C A:GLY1269 4.2 16.3 1.0
CD2 A:LEU1196 4.2 21.2 1.0
CB A:LEU1196 4.3 18.1 1.0
CD1 A:LEU1256 4.5 13.9 1.0
CA A:GLY1269 4.6 14.1 1.0
CB A:VAL1180 4.8 13.8 1.0
CD A:LYS1150 4.8 20.8 1.0
CG1 A:VAL1180 4.9 14.3 1.0
O A:HOH1666 4.9 17.8 1.0

Reference:

R.T.Lewis, C.M.Bode, D.M.Choquette, M.Potashman, K.Romero, J.C.Stellwagen, Y.Teffera, E.Moore, D.A.Whittington, H.Chen, L.F.Epstein, R.Emkey, P.S.Andrews, V.L.Yu, D.C.Saffran, M.Xu, A.Drew, P.Merkel, S.Szilvassy, R.L.Brake. The Discovery and Optimization of A Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (Alk) Inhibitors with Potential Utility For the Treatment of Cancer. J.Med.Chem. V. 55 6523 2012.
ISSN: ISSN 0022-2623
PubMed: 22734674
DOI: 10.1021/JM3005866
Page generated: Thu Aug 1 01:38:07 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy